http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2302087-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35bf375e2166308937c1d78356543ffc |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-30 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-30 |
| filingDate | 1975-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1976-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2302087-A1 |
| titleOfInvention | NEW DERIVATIVES OF PHENYLBUTYRIC ACID AND THEIR PREPARATION PROCESS |
| abstract | The medical use of 2-(4-isobutylphenyl)butyric acid of formula (I) and its non-toxic organic or inorganic salts is new. Pref. compsns. contain 100-600 mg (I) or its salt plus vehicles or excipients appropriate for oral, rectal or parenteral administration. (I) has analgesic, anti-inflammatory and antipyretic activities. It does not irritate the gastric mucosa, evan after prolonged administration and has a very low toxicity (no figures). A typical capsule contains 200 mg (I) Na salt; 35 mg talc and 5 mg Mg stearate. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9417787-A1 |
| priorityDate | 1975-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.